04.09.13
NattoPharma, Oslo, Norway, has appointed Eric Anderson senior vice president global sales and marketing. In this newly established role, Mr. Anderson will direct the global sales and marketing platform for NattoPharma’s proprietary products, including the MenaQ7 brand vitamin K2 portfolio. Additionally, he will create and maintain the North American headquarters for NattoPharma, directing strategic sales and marketing activities.
"Eric Anderson has a solid track record of launching and promoting science-based ingredients into strong brands," Frode Marc Bohan, Chairman of the Board for NattoPharma ASA, says. "He is the ideal executive leader to further the goal of widespread consumer use of MenaQ7 and MenaQ7 Crystals internationally."
Bohan continues, “When NattoPharma initially launched MenaQ7, I was actively running the marketing and together Eric and I established MenaQ7 as the dominating brand for vitamin K2 in US. I am very much looking forward to reestablishing the US market for MenaQ7 in close collaboration with Eric.”
NattoPharma has recently announced results of its three-year study on MenaQ7 brand vitamin K2 menaquinone-7 demonstrating its benefits by significantly reducing bone loss and improving bone strength. NattoPharma has also announced its ongoing program to develop vitamin K2 technologies for pharmaceutical applications.
Mr. Anderson has been a member of the natural products industry for more than 20 years, introducting several successful novel ingredients, including Chitosan, Tonalin CLA and MenaQ7 natural vitamin K2. Most recently, he was responsible for establishing the North American offices for Aker BioMarine Antarctic promoting Superba brand krill oil.
"Eric Anderson has a solid track record of launching and promoting science-based ingredients into strong brands," Frode Marc Bohan, Chairman of the Board for NattoPharma ASA, says. "He is the ideal executive leader to further the goal of widespread consumer use of MenaQ7 and MenaQ7 Crystals internationally."
Bohan continues, “When NattoPharma initially launched MenaQ7, I was actively running the marketing and together Eric and I established MenaQ7 as the dominating brand for vitamin K2 in US. I am very much looking forward to reestablishing the US market for MenaQ7 in close collaboration with Eric.”
NattoPharma has recently announced results of its three-year study on MenaQ7 brand vitamin K2 menaquinone-7 demonstrating its benefits by significantly reducing bone loss and improving bone strength. NattoPharma has also announced its ongoing program to develop vitamin K2 technologies for pharmaceutical applications.
Mr. Anderson has been a member of the natural products industry for more than 20 years, introducting several successful novel ingredients, including Chitosan, Tonalin CLA and MenaQ7 natural vitamin K2. Most recently, he was responsible for establishing the North American offices for Aker BioMarine Antarctic promoting Superba brand krill oil.